TRU-SENTIMENT · DeltaNeutral
VERA Trading Analysis - 09/15/2026 01:26 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
VERA (Vera Therapeutics, Inc. Class A Common Stock) at $32.99. True Sentiment Bearish, delta 40-60 call 6% / put 94%, call $437,670 vs put $6,529,000. RSI 41.5.
- Symbol
- VERA
- Price
- $32.99
- Article bias (separate from True Sentiment)
- bearish
- Conviction
- medium
- Published
- 2026-09-15 13:26:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Overall options flow sentiment: Bearish
Call vs Put dollar volume:
- Call: $437,670 (6.3%)
- Put: $6,529,000 (93.7%)
The options flow is heavily bearish, with a large put-to-call ratio.
Key Statistics: VERA
Fundamental Snapshot
Valuation
| P/E (Trailing) | -5.81 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 17.34 |
Profitability
| EPS (Trailing) | $-5.86 |
| EPS (Forward) | N/A |
| ROE | -98.56% |
| Net Margin | N/A |
Financial Health
| Revenue (TTM) | N/A |
| Debt/Equity | 0.18 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for VERA include:
- Vera Therapeutics Presents Positive 18-Month Data from Phase 2b Clinical Trial of VERVE-101 for the Treatment of Heterozygous Familial Hypercholesterolemia (HeFH)
- Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Vera Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
These headlines suggest that VERA has been making progress in its clinical trials and financial reporting, which could be impacting the stock's price action.
Fundamental Analysis:
Based on the provided FUNDAMENTALS data:
- Trailing EPS: -$5.86
- Trailing P/E: -5.81
- Price-to-Book: 17.34
- Debt-to-Equity: 0.18
- Return on Equity (ROE): -0.99
The negative EPS and P/E ratio indicate that the company is currently not profitable. The high price-to-book ratio and negative ROE are also concerns. However, the low debt-to-equity ratio is a positive sign.
Current Market Position:
Current price: $33.04
Recent price action: The stock has been volatile, with a significant drop in the past few days.
Key support and resistance levels:
- Support: $32.84 (recent low)
- Resistance: $35.00 (recent high)
Technical Analysis:
SMA trends:
- 5-day SMA: $33.90
- 20-day SMA: $34.12
- 50-day SMA: $34.93
RSI (14): 41.5
MACD: -0.01 (neutral)
Bollinger Bands:
- Middle: $34.12
- Upper: $36.85
- Lower: $31.38
The stock is currently below its SMAs, indicating a downtrend. The RSI is neutral, and the MACD is not showing a clear direction.
True Sentiment Analysis (Delta 40-60 Options):
Overall options flow sentiment: Bearish
Call vs Put dollar volume:
- Call: $437,670 (6.3%)
- Put: $6,529,000 (93.7%)
The options flow is heavily bearish, with a large put-to-call ratio.
Key Price Levels:
- Support: $32.84
- Resistance: $35.00
- Entry: $33.00
- Target: $35.00
- Stop Loss: $32.00
25-Day Price Forecast:
VERA is projected for $30.00 to $38.00
Based on current technical trends, momentum, and indicators, the stock price is expected to move within this range.
Defined Risk Strategy Recommendations:
Based on the price forecast, here are three defined risk strategy recommendations:
- Bull Call Spread: Buy $30.00 call, sell $35.00 call
- Bear Put Spread: Buy $35.00 put, sell $30.00 put
- Iron Condor: Sell $30.00 put, buy $35.00 put, sell $35.00 call, buy $40.00 call
Risk Factors:
- Technical warning signs: The stock is below its SMAs, indicating a downtrend.
- Sentiment divergences: The options flow is bearish, while the technical indicators are neutral.
- Volatility: The stock has been volatile, with a large ATR value.
Summary & Conviction Level:
Overall bias: Bearish
Conviction level: Medium
One-line trade idea: VERA may experience a short-term bounce but is likely to continue its downtrend.
View VERA Options Chain